Clinical Trial Update: A Study of Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating siremadlin alone and in combination with donor lymphocyte infusion for acute myeloid leukemia after allogeneic stem cell transplantati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Donor Lymphocyte Infusion
• Siremadlin (siremadlin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Acute Myeloid Leukemia, Allogeneic Stem Cell Transplantation | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-01-14